New cough science publications vetted and collected in one place
Key Takeaway: This study of 147 women with refractory/unexplained chronic cough found 44% of women experienced cough-related stress urinary-incontinence (SUI), and nearly half were undiagnosed. Both diagnosed and undiagnosed groups reported similar negative effects on their general health and quality of life, greater than was reported by those without cough-related SUI.
Why It Matters: By highlighting the underdiagnosis and significant impact of cough-related stress urinary incontinence (SUI) in women with chronic cough, this study points to the need for greater awareness and improved screening tools. It also suggests a need for cough-related SUI-targeted therapies.
Key Takeaway: Researcher investigated the effectiveness of fever as a diagnostic indicator of Covid-19 in vaccinated individuals. The study, conducted in Japan, found that vaccinated individuals were significantly less likely to experience fever compared to unvaccinated individuals. In contrast, cough and sore throat were more frequently observed in the vaccinated group.
Why It Matters: The study suggests that cough and sore throat may be more reliable indicators for COVID-19 in vaccinated individuals. The findings emphasize that relying on fever alone could lead to underdiagnosis in vaccinated populations.
Key Takeaways: This systematic review of 59 studies with 7,431 patients found that anti-reflux surgery offers long-term relief from gastroesophageal reflux disease (GERD) symptoms, particularly cough.
Why it matters: The study supports the use of anti-reflux surgery for patients with GERD symptoms, but also demonstrates the need for further research to identify predictors of success.
Plus…
A Cough Science Forum Special
Watch Hyfe’s 8th Cough Science Forum, a quarterly Zoom event hosted by Hyfe that features recent and ongoing research in cough science, available via on-demand video.
Agenda:
Internet behavioral cough suppression therapy: brief recap of a randomized, sham-treatment controlled trial
Speaker: Jane Reynolds PhD CCC-SLP, Assistant Professor University of Montana, Co-Director VOICES Lab
The use of real-time cough monitoring of acute exacerbations of pulmonary sarcoidosis: a pilot study
Speaker: Marc A. Judson, MD, Albany Medical College
It’s a bout time: cough bouts as a measure of severity
Speaker: Carlos Chaccour, Hyfe team
“It seems to me questionable that someone should be on a dose of corticosteroids which can cause toxicity for months, when we could see the effect of the intervention sooner, which may adjust our therapy.” - Marc Judson, on the potential of cough-monitoring in pulmonary sarcoidosis.
Watch the full video here.
CHEST Annual Meeting, Boston: Hyfe’s CMO Dr Peter Small will be in Boston next week, Oct 6-9th, meeting with a diverse group of pulmonologists, critical care physicians, respiratory therapists, researchers, and healthcare professionals specializing in chest medicine and respiratory care. Get in touch if you’re attending and would like a demo of continuous cough-monitoring!
Given that cough monitoring remains a significant endpoint in clinical trials, and the absence of FDA-cleared devices or technologies for cough monitoring, we have published an ‘Overview of Regulatory Status for Current Cough Counting Devices on the Market’. Read it here.
